; (B) synthesizes information relating to individuals experiencing post-acute sequelae of COVID–19 identified from the survey described in paragraph (1) and information under the patient registry described in paragraph (2); and (3) outreach and inclusion (as appropriate) individuals from communities with traditional health disparities and inequities. (c) Report Not later than 1 year after the establishment of the synthesized patient registry described in subsection (a)(2), and annually thereafter, the Patient-Centered Outcomes Research Institute shall submit data, findings, and information with respect to the status of the patient registry (including progress, barriers, and issues) to Congress and the President. (d) Authorization of appropriations There is hereby authorized $30,000,000 for fiscal year 2021 to carry out this section, which shall remain available until expended. 3. Authorization of appropriations for research with respect to individuals experiencing post-acute sequelae of COVID–19 by the NIH (a) In general The Director of the National Institutes of Health conduct research with respect to individuals experiencing post-acute sequelae of COVID–19. (b) Authorization of appropriations There is hereby authorized $100,000,000 for fiscal year 2021 to carry out this section, which shall remain available until expended.